ASAthena P. Souka

Athena P. Souka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Athena P. Souka has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Athanasios Pilalis

    Faculty of Medicine: Ethniko kai Kapodistriako Panepistemio Athenon Iatrike Schole Kapodistrian University of Athens

    6 shared publications
  • Panagiotis Antsaklis

    Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens—Faculty of Medicine, Athens, Greece

    4 shared publications
  • George Daskalakis

    Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens—Faculty of Medicine, Athens, Greece

    3 shared publications
  • Ioannis Papastefanou

    Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece

    3 shared publications
  • Maria Papamihail

    Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens—Faculty of Medicine, Athens, Greece

    3 shared publications
  • G. Daskalakis

    1st Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

    2 shared publications

Latest Publications

  • Open Access

    Prognostic value of cervical length for spontaneous preterm birth in asymptomatic women with singleton pregnancy: An individual participant data meta-analysis

    by Kelly Hughes, David Nguyen, Mason Aberoumand, Heather Ford, Erin Clarke, Nuria Banos Lopez, Margaret Dziadosz, Richard Fischer, Renato T. Souza, Jose Guilherme Cecatti, et al.

    Background: Spontaneous preterm birth (SPTB) is the leading cause of perinatal and early childhood mortality worldwide. Studies have generally suggested that mid-trimester transvaginal sonographic cervical length n = 91,404). Mean cervical length was 40 mm (standard deviation [SD] 9 mm) at about 20 weeks’ gestation. SPTB <37 weeks occurred in 4,442 (5.2%) participants. An L-shape non-linear association between cervical length and SPTB was observed. A longer cervical length was associated with steeply lower odds of SPTB until it reached 40 mm, beyond which the odds of SPTB became stable. This means that compared to a woman with a cervical length of 40 mm, those with a cervical length of 20 and 30 mm were associated 6.22 and 2.10 higher odds of SPTB (95% confidence intervals [4.76, 8.13] and [1.85, 2.38]), respectively. Limitations included suboptimal data retrieval rate (51% of all eligible participants) and a lack of comprehensive co-predictors of SPTB across all datasets. Conclusion: We found a non-linear association between cervical length and SPTB. We found a non-linear association between cervical length and SPTB. Shorter cervix is associated with progressively higher risk of SPTB when length is less than 40 mm, but probability of term birth is high when cervical length is over 40 mm.

  • Reply

    by K. Gadsbøll, N. Brix, P. Sandager, O. B. Petersen, A. P. Souka, K. H. Nicolaides, I. Vogel

  • Open Access

    Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study

    by K. Gadsbøll, N. Brix, P. Sandager, O. B. Petersen, A. P. Souka, K. H. Nicolaides, I. Vogel

    Objective: To assess the outcome of pregnancies with increased fetal nuchal translucency (NT) thickness and a normal result from chromosomal microarray (CMA) vs conventional karyotyping.Methods: This was a Danish nationwide registry‐based cohort study of all singleton pregnancies seen for combined first‐trimester screening between 2008 and 2018. Data on NT thickness and pregnancy outcome were retrieved from the Danish Fetal Medicine Database, whereas data on cytogenetic and molecular karyotypes were retrieved from the Danish Cytogenetic Central Register. Pregnancies were stratified according to NT thickness, and we computed the prevalence of chromosomal aberration, termination of pregnancy (due to non‐genetic abnormal findings aside from increased NT), pregnancy loss, major congenital malformation and unaffected live birth (live birth ≥ 24 weeks' gestation with no chromosomal aberration or major congenital malformation diagnosed). The prevalence of the different outcomes was further estimated for pregnancies with increased NT (≥ 3.5 mm) and a normal CMA result. Finally, to assess the impact of CMA compared with conventional karyotyping for increased NT, we compared the prevalence of chromosomal aberrations and each pregnancy outcome between the periods 2008–2012 and 2014–2018 (during which < 3% and > 60%, respectively, of pregnancies with increased NT were examined using CMA).Results: We identified 557 896 pregnancies with a NT measurement for which outcome data were registered. Fetal NT was ≥ 3.5 mm in 3717 (0.7%) pregnancies, of which 3368 (91%) underwent genetic examination. The prevalence of chromosomal aberrations increased significantly with increasing NT thickness, from 21% in pregnancies with NT of 3.5–4.4 mm to 69% in pregnancies with NT ≥ 6.5 mm. Trisomies 21, 18 and 13 accounted for the majority of chromosomal aberrations diagnosed in all subgroups of increased NT (range, 61–87%). In pregnancies with increased NT and a normal CMA result, the prevalence of unaffected live birth decreased significantly from 87% for NT of 3.5–4.4 mm to 29% for NT ≥ 6.5 mm. Increased uptake of CMA during 2014–2018 compared with 2008–2012 slightly increased the detection of submicroscopic aberrations. However, a normal CMA result, compared with a normal result from conventional karyotyping, did not substantially improve the prognosis in pregnancies with increased NT.Conclusions: Our study reaffirms the association between increased NT and chromosomal aberrations. Although CMA improves diagnostic resolution in pregnancies with increased NT, a normal test result does not substantially impact the prevalence of unaffected live births. This highlights the ongoing need for accurate clinical guidance and continued research, especially as whole‐genome sequencing is increasingly adopted in prenatal care. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


  • Cervical length evolution in pregnancy and prediction of preterm delivery

    by A. P. Souka, V. Maritsa, P. Antsaklis, A. Pilalis, G. Daskalakis

    Purpose To construct reference charts for cervical length (CL) in pregnancy based on longitudinal measurements and to assess the value of measuring cervical length after 24 weeks of gestation. Methods CL was measured transvaginally in singleton pregnancies at 5 to 41 weeks. Pregnancies with more than one measurement were used for creating the CL chart, whereas any measurement after 24 weeks was considered for assessing the correlation of CL with preterm delivery. Results The dataset consisted of 12,601 pregnancies and 33,899 observations. Gestational age was the main predictor of CL (R2 = 67.3%). Further adjustments in the fixed effects part for maternal characteristics (age, BMI, smoking status, parity, history of miscarriage, and cervical surgery) improved the prediction ability (R2 = 78.4%). CL was predictive of spontaneous preterm delivery before 37 weeks when measured at any gestation between 24 and 35 weeks and it was predictive of spontaneous preterm delivery before 32 weeks when measured between 28 and 31 weeks (AUC = 0.68). Conclusion Gestational age is the main predictor of CL followed by maternal characteristics and history. CL assessment between 24 and 35 + 6 weeks can enhance our ability to predict spontaneous preterm delivery.


  • The role of the PLGF in the prediction of the outcome in pregnancies with a small for gestational age fetus

    by Athena P. Souka, Panagiotis Antsaklis, Konstantinos Tassias, Maria Anna Chatziioannou, Maria Papamihail, George Daskalakis

    Purpose To explore the value of measuring maternal serum PLGF in the prediction of the outcome of small for gestational age fetuses (SGA ). Methods Singleton pregnancies referred with suspicion of SGA in the third trimester were included if they had: no indication for nor signs of imminent delivery, fetal abdominal circumference (AC) at or below the 10th centile and/or estimated fetal weight (EFW) at or below the 10th centile and/or umbilical artery pulsatility index (Umb-PI) at or above the 90th centile for gestation. Women with pre-eclampsia at presentation were excluded. Maternal blood was drawn at the first (index) visit and analyzed retrospectively. Results Fifty-one fetuses were examined. Multiple regression analysis showed that family history of microsomia, index EFW and PLGF were significant predictors of the birthweight centile; index femur length centile and PLGF were significant predictors of pre-eclampsia; PLGF and index systolic blood pressure were significant predictors of iatrogenic preterm delivery < 37 weeks, whereas PLGF and index EFW were significant predictors of birthweight ≤ 5th centile and admission to the neonatal intensive care unit. For all outcomes, the addition of maternal–fetal parameters did not improve the prediction compared to PLGF alone. Using a cutoff of 0.3 MoM for PLGF would identify 94.1% of the pregnancies with iatrogenic preterm delivery and/or intra-uterine death and all of the cases that developed pre-eclampsia, for a screen positive rate of 54.9%. Women with PLGF ≤ 0.3 MoM had a poor fetal/maternal outcome (iatrogenic preterm delivery, pre-eclampsia, intra-uterine death) in 61.5% of cases. Conclusion In pregnancies complicated by SGA, PLGF identifies a very high-risk group that may benefit from intense surveillance.


  • The role of the PLGF in the management of pregnancies complicated with fetal microsomia

    by Athena P. Souka, M. I. Chatziioannou, A. Pegkou, P. Antsaklis, G. Daskalakis

    Purpose To explore the contribution of maternal and fetal parameters in predicting the time interval between diagnosis and development of adverse events leading to delivery in singleton pregnancies complicated with fetal microsomia. Methods Prospective study on singleton pregnancies referred to a tertiary center because of suspicion of fetal smallness in the third trimester. The study cohort included cases with fetal abdominal circumference (AC) ≤ 10th centile or estimated fetal weight ≤ 10th centile or umbilical artery pulsatitlity index ≥ 90th centile. Development of pre-eclampsia, fetal demise, and fetal deterioration diagnosed by fetal Doppler studies or fetal heart rate monitoring and leading to delivery were considered as adverse events. Maternal demographics, obstetric history, blood pressure, serum PLGF, and fetal Doppler studies were explored as predictors of the time interval between the first visit to the clinic and the diagnosis of complications. Results In 59 women, the median incubation period from presentation to the clinic to an adverse event was 6, 2 weeks, whereas half of the pregnancies (52.5%) did not develop any adverse event. PLGF was the strongest predictor of adverse events. Both PLGF in raw values and PLGF MOM had equally good predictive ability (AUC 0.82 and 0.78 respectively). Optimal cut-off points were 177.7 pg/ml for PLGF raw values (sensitivity 83% and specificity 66.7%) and 0.277 MoM (sensitivity 76% and specificity 86.7%). On multiple Cox regression analysis, maternal systolic blood pressure, PLGF, fetal increased umbilical artery PI, and reduced CP ratio were independently associated with adverse events. Half of the pregnancies with low PLGF and only one in ten with high PLGF were delivered within two weeks after the initial visit. Conclusion Half of the pregnancies carrying a small fetus in the third trimester will not develop maternal or fetal complications. PLGF is a strong predictor of adverse events that can be used to customize antenatal care.


  • Open Access

    Influence of anti-coagulant therapy in the first trimester uterine flow indices

    by Athena Souka, Konstantinos Tasias, George Asimakopoulos, Athanasios Pilalis

    Purpose: to explore the impact of anticoagulants (aspirin and/or low molecular weight heparin (LMWH)) in the uterine artery flow at 11-13 weeks of gestation. Materials and Methods: retrospective study on singleton viable pregnancies presenting for routine 11-13 weeks’ ultrasound scan. Maternal and fetal variables were assessed as to their influence on uterine artery pulsatility index (UtA-PI). Results: 5,606 pregnancies were analyzed. Increasingmaternal age, higher BMI, large fibroids and higher PAPP-A levels were associated with lower Ut-A PI, whereas history of pre-eclampsia/hypertension in a previous pregnancy, smoking and increased fetal ductus venosus PI were associated with higher Ut-A PI levels. The strongest effect was exerted by history of PET/hypertension, maternal PAPP-A MoM and fetal ductus venosus PI. Anticoagulant treatment had no significant influence. Conclusion: prior treatment with aspirin and/or LMWH does not alter the Ut-A PI. Screening models for pre-eclampsia can be used in women receiving anti-coagulant therapy.

  • Open Access

    The role of the PLGF in the management of pregnancies complicated with fetal microsomia.

    by Athena Souka, Maria Ioanna Chatziioannou, Afrodite Pegkou, Panagiotis Antsaklis, George Daskalakis

    Purpose To explore the contribution of maternal and fetal parameters in predicting the time interval between diagnosis and development of adverse events leading to delivery in singleton pregnancies complicated with fetal microsomia. Methods Prospective study on singleton pregnancies referred to a tertiary centre because of suspicion of fetal smallness in the third trimester. The study cohort included cases with fetal abdominal circumference (AC) ≤ 10th centile or estimated fetal weight ≤ 10th centile or umbilical artery pulsatitlity index ≥ 90th centile. Development of pre-eclampsia, fetal demise and fetal deterioration diagnosed by fetal Doppler studies or fetal heart rate monitoring and leading to delivery were considered as adverse events. Maternal demographics, obctetric history, blood pressure, serum PLGF and fetal Doppler studies were explored as predictors of the time interval between the first visit to the clinic and the diagnosis of complications. Results In 59 women the median incubation period from presentation to the clinic to an adverse event was 6,2 weeks, whereas half of the pregnancies (52.5%) did not develop any adverse event. PLGF was the strongest predictor of adverse events. Both PLGF in raw values and PLGF MOM had equally good predictive ability (AUC 0.82 and 0.78 respectively). Optimal cut-off points were 177.7pg/ml for PLGF raw values (sensitivity 83% and specificity 66.7%) and 0.277 MoM (sensitivity 76% and specificity 86.7%). On multiple Cox regression analysis maternal systolic blood pressure and PLGF and fetal increased umbilical artery PI and reduced CP ratio were independently associated with adverse events. Half of the pregnancies with low PLGF and only one in ten with high PLGF were delivered within two weeks after the initial visit. Conclusion Half of the pregnancies carrying a small fetus in the third trimester will not develop maternal or fetal complications. PLGF is a strong predictor of adverse events that can be used to customize antenatal care.

  • Open Access

    The role of the PLGF in the prediction of the outcome in pregnancies complicated with fetal microsomia

    by Athena Souka, Panagiotis Antsaklis, Konstantinos Tassias, Maria Ioanna Chatziioannou, Maria Papamihail, George Daskalakis

    Purpose to explore the value of measuring maternal serum PLGF in the prediction of the outcome of microsomic fetuses. Methods Singleton pregnancies referred with suspicion of microsomia were included if they had: no indication for nor signs of imminent delivery, fetal abdominal circumference (AC) at or below the 10th centile and/or estimated fetal weight (EFW) at or below the 10th centile and/or umbilical artery pulsatility index (Umb-PI) at or above the 90th centile for gestation. Women with pre-eclampsia at presentation were excluded. Maternal blood was drawn at the first (index) visit and analyzed retrospectively. Results 51 fetuses were examined. Multiple regression analysis showed that history of microsomia, index EFW and PLGF were significant predictors of the birthweight centile; index femur length centile and PLGF were significant predictors of pre-eclampsia; PLGF and index systolic blood pressure were significant predictors of iatrogenic preterm delivery < 37 weeks whereas PLGF and index EFW were significant predictors of birthweight ≤ 5th centile and admission to the neonatal intensive care unit. For all outcomes the addition of maternal-fetal parameters did not improve the prediction compared to PLGF alone. Using a cut off of 0.3 MoM for PLGF would identify 94.1% of the pregnancies with iatrogenic preterm delivery and/or intra-uterine death and all of the cases that developed pre-eclampsia, for a screen positive rate of 54.9%. Women with PLGF ≤ 0.3 MoM had a poor fetal/maternal outcome (iatrogenic preterm delivery, pre-eclampsia, intra-uterine death) in 61.5% of cases. Conclusion In pregnancies complicated by fetal microsomia PLGF identifies a very high-risk group that may benefit from intense surveillance.

  • Open Access

    Screening vs. no screening for preterm delivery in low-risk singleton pregnancies: comparison by propensity score analysis

    by Athena P. Souka, Vasiliki Areti Maritsa, Makarios Eleftheriades

    Purpose: To compare the effect of a policy of screening for spontaneous preterm delivery (SPD) by transvaginal cervical length (CL) measurement versus a no screening policy in the prevention of severe prematurity. Methods: Retrospective study on low-risk singleton pregnancies examined at 20–24 weeks. Two cohorts, one with SPD screening and the other without screening, were matched using propensity analysis to create the study groups. Women with short CL were treated with vaginal progesterone and/or cervical cerclage/pessary. The outcomes examined were SPD < 32 weeks (SPD 32) and SPD between 20 and 32 weeks (SPD 20–32). Results: Screening for SPD was associated with a significant reduction in the rate of SPD at less than 32 weeks (0.3 vs. 0.8%, p = 0.001 in the screened and no screened pregnancies, respectively) and in the rate of SPD 20–32 (0.3 vs. 0.9%, p = 0.005 in the screened and no screened pregnancies, respectively). After adjusting for maternal age, parity, body mass index, smoking and mode of conception, the screening group had significantly lower hazard for SPD 20–32 (HR = 0.36, 95% CI: 0.18–0.75, p = 0.006) and SPD32 (HR = 0.39, 95% CI: 0.19–0.82, p = 0.013). Conclusion: Screening for SPD by transvaginal CL measurement in mid-pregnancy may reduce the incidence of severe prematurity in low-risk singleton pregnancies.